Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells

Nature Communications

Volumn 7, Issue , 2016, Pages

  Zhao, Yinghua ^a   Chu, Xiao ^a   Chen, Jintong ^a   Wang, Ying ^a   Gao, Sujun ^a   Jiang, Yuxue ^a   Zhu, Xiaoqing ^a   Tan, Guangyun ^a   Zhao, Wenjie ^b   Yi, Huanfa ^b   Xu, Honglin ^c   Ma, Xingzhe ^d   Lu, Yong ^d   Yi, Qing ^a,d   Wang, Siqing ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

^c National Vaccine and Serum Institute   (China)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURDLAN; DECTIN 1; DENDRITIC CELL VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 9; OX40 LIGAND; PROTEIN; PROTEIN KINASE SYK; PROTEIN P50; RAF1 PROTEIN; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; BETA GLUCAN; CHEMOKINE; LECTIN; RAF PROTEIN; TNFSF15 PROTEIN, MOUSE;

CELLS AND CELL COMPONENTS; GENE EXPRESSION; IMMUNITY; IMMUNIZATION; RODENT; TRANSLOCATION; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL NUCLEUS; CONTROLLED STUDY; DENDRITIC CELL; GENE OVEREXPRESSION; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MELANOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH9 CELL; UPREGULATION; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CROSS PRESENTATION; DRUG EFFECT; HELPER CELL; HUMAN; IMMUNITY; IMMUNOLOGY; METABOLISM; NEOPLASM;

MUS;

ANIMALS; BETA-GLUCANS; CELL DIFFERENTIATION; CHEMOKINES; CROSS-PRIMING; DENDRITIC CELLS; HUMANS; IMMUNITY; LECTINS, C-TYPE; MICE, INBRED C57BL; NEOPLASMS; NF-KAPPA B; OX40 LIGAND; PROTO-ONCOGENE PROTEINS C-RAF; SIGNAL TRANSDUCTION; SYK KINASE; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 84981193884     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms12368     Document Type: Article

References (39)

1. Zhu, J., Yamane, H., Paul, W. E. Differentiation of effector CD4 T cell populations (). Annu. Rev. Immunol. 28, 445-489 (2010).
2. O'Shea, J. J., Lahesmaa, R., Vahedi, G., Laurence, A., Kanno, Y. Genomic views of STAT function in CD4\+ T helper cell differentiation. Nat. Rev. Immunol. 11, 239-250 (2011).
3. Dardalhon, V. et al. IL-4 inhibits TGF-beta-induced Foxp3\+ T cells and, together with TGF-beta, generates IL-9\+ IL-10\+ Foxp3(-) effector T cells. Nat. Immunol. 9, 1347-1355 (2008).
4. Veldhoen, M. et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341-1346 (2008).
5. Noelle, R. J., Nowak, E. C. Cellular sources and immune functions of interleukin-9. Nat. Rev. Immunol. 10, 683-687 (2010).
6. Soroosh, P., Doherty, T. A. Th9 and allergic disease. Immunology 127, 450-458 (2009).
7. Purwar, R. et al. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat. Med. 18, 1248-1253 (2012).
8. Lu, Y. et al. Th9 cells promote antitumor immune responses in vivo. J. Clin. Invest. 122, 4160-4171 (2012).
9. Lu, Y., Yi, Q. Utilizing T9 cells as a novel therapeutic strategy for malignancies. Oncoimmunology 2, e23084 (2013).
10. Lu, Y. et al. Tumor-specific IL-9-producing CD8\+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers. Proc. Natl Acad. Sci. USA 111, 2265-2270 (2014).
11. Xiao, X. et al. OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat. Immunol. 13, 981-990 (2012).
12. Yao, W. G. et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 38, 360-372 (2013).
13. Anuradha, R. et al. IL-4-, TGF-beta-, and IL-1-dependent expansion of parasite antigen-specific Th9 cells is associated with clinical pathology in human lymphatic filariasis. J. Immunol. 191, 2466-2473 (2013).
14. Vegran, F. et al. The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells. Nat. Immunol. 15, 758-766 (2014).
15. Schmitt, E. et al. Il-9 production of naive Cd4(\+) T-cells depends on Il-2, is synergistically enhanced by a combination of Tgf-beta and Il-4, and is inhibited by Ifn-gamma. J. Immunol. 153, 3989-3996 (1994).
16. Angkasekwinai, P. et al. Interleukin-25 (IL-25) promotes efficient protective immunity against trichinella spiralis infection by enhancing the antigen-specific IL-9 response. Infect. Immun. 81, 3731-3741 (2013).
17. Ito, T. et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 202, 1213-1223 (2005).
18. Sutton, C., Brereton, C., Keogh, B., Mills, K. H. G., Lavelle, E. C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203, 1685-1691 (2006).
19. Chung, Y. et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30, 576-587 (2009).
20. Paul, W. E., Zhu, J. F. How are T(H)2-type immune responses initiated and amplified? Nat. Rev. Immunol. 10, 225-235 (2010).
21. Liao, W., Lin, J. X., Leonard, W. J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38, 13-25 (2013).
22. Timmerman, J. M., Levy, R. Dendritic cell vaccines for cancer immunotherapy. Annu. Rev. Med. 50, 507-529 (1999).
23. Randolph, G. J., Ochando, J., Partida-Sanchez, S. Migration of dendritic cell subsets and their precursors. Annu. Rev. Immunol. 26, 293-316 (2008).
24. Gringhuis, S. I. et al. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappa B activation through Raf-1 and Syk. Nat. Immunol. 10, 203-213 (2009).
25. Taylor, P. R. et al. The beta-glucan receptor, dectin-1, is predominantly expressed on the, surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol. 169, 3876-3882 (2002).
26. Romani, L. Immunity to fungal infections. Nat. Rev. Immunol. 4, 11-23 (2004).
27. LeibundGut-Landmann, S. et al. Syk-and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8, 630-638 (2007).
28. Acosta-Rodriguez, E. V. et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8, 639-646 (2007).
29. Joo, H. et al. Opposing roles of dectin-1 expressed on human plasmacytoid dendritic cells and myeloid dendritic cells in Th2 polarization. J. Immunol. 195, 1723-1731 (2015).
30. Kim, I. K. et al. Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells. Nat. Med. 21, 1010-1017 (2015).
31. Hou, B., Reizis, B., DeFranco, A. L. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and-extrinsic mechanisms. Immunity 29, 272-282 (2008).
32. Rivera, A. et al. Dectin-1 diversifies Aspergillus fumigatus-specific T cell responses by inhibiting T helper type 1 CD4 T cell differentiation. J. Exp. Med. 208, 369-381 (2011).
33. Rogers, N. C. et al. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22, 507-517 (2005).
34. Gross, O. et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442, 651-656 (2006).
35. Richard, A. C. et al. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells (vol 194, pg 3567, 2015). J. Immunol. 195, 5839-5840 (2015).
36. Nishimura, T. et al. The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother. Pharmacol. 46, S52-S61 (2000).
37. Ji, Y. Q., Zhang, W. G. Th17 cells: positive or negative role in tumor? Cancer Immunol. Immun. 59, 979-987 (2010).
38. Xie, J. et al. Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38. J. Immunol. 171, 4792-4800 (2003).
39. Capitini, C. M., Guimond, M., Mackall, C. L., Fry, T. J. GVHD abrogates T cell responses to dendritic cell vaccines but not vaccine-induced proliferation. Blood 110, 534a-534a (2007).